Sensus Healthcare, Inc.
SRTS · NASDAQ
Bulios Fair Price
$2.11
31.3% downside
Current Price
$3.07
According to Bulios Fair Price, SRTS is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Sensus Healthcare, Inc. (SRTS) is a company specializing in the development and provision of advanced technologies for the treatment of cancer and dermatological conditions. With over a decade of history, Sensus Healthcare focuses on innovative approaches, such as low-dose radiation therapy, that selectively target tumor cells and minimize effects on surrounding healthy tissues. Their technologies offer patients and physicians alternative treatment options with an emphasis on effectiveness and reduced invasiveness. Sensus Healthcare, Inc. (SRTS) contributes to the advancement of sophisticated treatment methods and the improvement of quality of life for patients with cancer and dermatological conditions. Sensus Healthcare, Inc. (SRTS) shares could be suitable for investors who want to support innovations in oncological and dermatological treatment and contribute to progress in therapeutic approaches.
Sector
Healthcare
Industry
Medical - Devices
CEO
Joseph C. Sardano
Employees
60
Headquarters
Boca Raton
Upcoming events
Earnings
Upcoming earnings report